Vijaya Diagnostic Centre: The financial results for the period ended September 30, 2026
Vijaya Diagnostic Centre (VIJAYA) filed a disclosure titled "The financial results for the period ended September 30, 2026". The company is valued at about ₹14,890 crore.
What happened
Vijaya Diagnostic Centre (VIJAYA) filed a disclosure with the exchanges on 3 November 2026 at 07:57 PM titled "The financial results for the period ended September 30, 2026".
Company snapshot
Vijaya Diagnostic Centre is a small-cap company in the Healthcare sector, with a market value of about ₹14,890 crore.
The stock last traded at ₹1,447.1, against a 52-week range of ₹848–₹1,593.6 (9.2% below the high).
Before this filing the shares had moved +1.4% over the month and +7.6% over three months. Average daily turnover over the last 20 sessions was about ₹16.22 crore.
Promoters held 52.51% at the end of Q1 FY27; 1.96% of promoter shares were pledged. Foreign institutions owned 11.66% and domestic institutions 31.61%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 188 | 38.3 | 3.76 |
| Q2 FY26 | 202 | 43.3 | 4.21 |
| Q3 FY26 | 205 | 43.2 | 4.2 |
| Q4 FY26 | 219 | 47.9 | 4.66 |
| Q1 FY27 | 231 | 53.1 | 5.16 |
What history shows
BCEIE's records show 2 previous results filings from the company since May 2026.
After those filings, the stock gained 1.7% on average the next trading day and was up 7.6% on average after five days (2 filings with price data).
Across 300 similar disclosures by other Healthcare companies, shares moved +1.4% on average the next day and +1.9% over five days; 57% of them rose the next day.
Market-wide, 10,609 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 6 Aug 2026 | A press release dated August 06, 2026, titled "Press Release on… | +1.7% | +7.6% |
| 6 Aug 2026 | , the financial results for the period ended Jun 30, 2026. | +1.7% | +7.6% |
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 3 November 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.